Boston Scientific Corporation's Revenue by Segment
In fiscal year , Boston Scientific Corporation's revenue by segment (products & services) are as follows:
Learn more about Boston Scientific Corporation’s Revenue by Geography
Check out competitors to Boston Scientific Corporation in a side-by-side comparison.
Explore additional financial metrics for Boston Scientific Corporation.
Cardiovascular | 8161000000 |
---|---|
MedSurg | 5057000000 |
Cardiovascular | 8819000000 |
---|---|
MedSurg | 5422000000 |
The above chart shows Boston Scientific Corporation's revenue percentage share by segment (products and services).
In fiscal year 2022, Boston Scientific Corporation's revenue by segment is as follows:
- Cardiovascular generated $8.16B in revenue, representing 61.74% of its total revenue.
- MedSurg generated $5.06B in revenue, representing 38.26% of its total revenue.
The biggest segment for Boston Scientific Corporation is the Cardiovascular, which represents 61.74% of its total revenue.
The smallest segment for Boston Scientific Corporation is the MedSurg, which represents 38.26% of its total revenue.
The above chart shows Boston Scientific Corporation's revenue percentage share by segment (products and services).
In fiscal year 2023, Boston Scientific Corporation's revenue by segment is as follows:
- Cardiovascular generated $8.82B in revenue, representing 61.93% of its total revenue.
- MedSurg generated $5.42B in revenue, representing 38.07% of its total revenue.
The biggest segment for Boston Scientific Corporation is the Cardiovascular, which represents 61.93% of its total revenue.
The smallest segment for Boston Scientific Corporation is the MedSurg, which represents 38.07% of its total revenue.
Summary Table
Products & Services (Percent Share) | 2022 | 2023 | 2024 |
---|---|---|---|
Cardiovascular | 61.74% | 61.93% | - |
MedSurg | 38.26% | 38.07% | - |
Total Revenue | 100% | 100% | 100% |
The above chart shows growth drivers and a year-over-year comparison of different segments' revenue.